Neurones S.A.

ENXTPA:NRO Stock Report

Market Cap: €865.2m

Neurones Past Earnings Performance

Past criteria checks 5/6

Neurones has been growing earnings at an average annual rate of 7.7%, while the IT industry saw earnings growing at 5.9% annually. Revenues have been growing at an average rate of 9.4% per year. Neurones's return on equity is 14.3%, and it has net margins of 6.2%.

Key information

7.70%

Earnings growth rate

8.06%

EPS growth rate

IT Industry Growth13.19%
Revenue growth rate9.39%
Return on equity14.25%
Net Margin6.23%
Last Earnings Update30 Jun 2026

Recent past performance updates

Analysis Article • Oct 02

Neurones (EPA:NRO) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Neurones S.A.'s ( EPA:NRO ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...

Recent updates

Analysis Article • Dec 03

These 4 Measures Indicate That Neurones (EPA:NRO) Is Using Debt Safely

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • Nov 07

Estimating The Intrinsic Value Of Neurones S.A. (EPA:NRO)

Key Insights The projected fair value for Neurones is €39.18 based on 2 Stage Free Cash Flow to Equity Neurones' €41.15...
Analysis Article • Oct 02

Neurones (EPA:NRO) Is Posting Promising Earnings But The Good News Doesn’t Stop There

Neurones S.A.'s ( EPA:NRO ) recent earnings report didn't offer any surprises, with the shares unchanged over the last...
Analysis Article • Aug 30

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

What trends should we look for it we want to identify stocks that can multiply in value over the long term? In a...
Analysis Article • Jun 24

Neurones (EPA:NRO) Has A Rock Solid Balance Sheet

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
Analysis Article • May 30

Neurones S.A.'s (EPA:NRO) CEO Looks Due For A Compensation Raise

Key Insights Neurones will host its Annual General Meeting on 5th of June Total pay for CEO Luc de Chammard includes...
Analysis Article • Apr 04

Neurones S.A.'s (EPA:NRO) Shares May Have Run Too Fast Too Soon

When close to half the companies in France have price-to-earnings ratios (or "P/E's") below 14x, you may consider...
Analysis Article • Jul 27

What Neurones S.A.'s (EPA:NRO) P/E Is Not Telling You

When close to half the companies in France have price-to-earnings ratios (or "P/E's") below 15x, you may consider...
Analysis Article • Apr 26

Returns On Capital At Neurones (EPA:NRO) Have Hit The Brakes

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Firstly, we'd want to...
Analysis Article • Dec 01

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article • May 18

If EPS Growth Is Important To You, Neurones (EPA:NRO) Presents An Opportunity

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...
Analysis Article • Feb 10

Neurones' (EPA:NRO) Returns Have Hit A Wall

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Amongst other...
Analysis Article • Oct 26

Slowing Rates Of Return At Neurones (EPA:NRO) Leave Little Room For Excitement

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...
Analysis Article • Sep 22

Does Neurones (EPA:NRO) Deserve A Spot On Your Watchlist?

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
Analysis Article • Apr 28

Neurones (EPA:NRO) Will Pay A Smaller Dividend Than Last Year

Neurones S.A. ( EPA:NRO ) has announced it will be reducing its dividend payable on the 10th of June to €1.00. However...
Analysis Article • Jan 25

Should You Be Adding Neurones (EPA:NRO) To Your Watchlist Today?

Some have more dollars than sense, they say, so even companies that have no revenue, no profit, and a record of falling...
Analysis Article • Jan 06

Returns At Neurones (EPA:NRO) Appear To Be Weighed Down

If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...
Analysis Article • Jul 20

Returns On Capital At Neurones (EPA:NRO) Paint A Concerning Picture

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article • May 06

Is Neurones S.A. (EPA:NRO) Trading At A 25% Discount?

In this article we are going to estimate the intrinsic value of Neurones S.A. ( EPA:NRO ) by taking the expected future...
Analysis Article • Mar 24

Some Investors May Be Worried About Neurones' (EPA:NRO) Returns On Capital

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
Analysis Article • Mar 09

Neurones S.A.'s (EPA:NRO) Stock's On An Uptrend: Are Strong Financials Guiding The Market?

Most readers would already be aware that Neurones' (EPA:NRO) stock increased significantly by 15% over the past three...
Analysis Article • Feb 16

The Neurones (EPA:NRO) Share Price Has Gained 54% And Shareholders Are Hoping For More

These days it's easy to simply buy an index fund, and your returns should (roughly) match the market. But you can do a...
Analysis Article • Jan 25

Here's Why Neurones's (EPA:NRO) Statutory Earnings Are Arguably Too Conservative

As a general rule, we think profitable companies are less risky than companies that lose money. However, sometimes...
Analysis Article • Jan 11

What Percentage Of Neurones S.A. (EPA:NRO) Shares Do Insiders Own?

If you want to know who really controls Neurones S.A. ( EPA:NRO ), then you'll have to look at the makeup of its share...
Analysis Article • Dec 28

Should Neurones S.A. (EPA:NRO) Be Part Of Your Dividend Portfolio?

Today we'll take a closer look at Neurones S.A. ( EPA:NRO ) from a dividend investor's perspective. Owning a strong...
Analysis Article • Dec 15

Are Neurones S.A. (EPA:NRO) Investors Paying Above The Intrinsic Value?

Does the December share price for Neurones S.A. ( EPA:NRO ) reflect what it's really worth? Today, we will estimate the...
Analysis Article • Dec 02

What We Learned About Neurones' (EPA:NRO) CEO Pay

The CEO of Neurones S.A. ( EPA:NRO ) is Luc de Chammard, and this article examines the executive's compensation against...
Analysis Article • Nov 17

Investors Who Bought Neurones (EPA:NRO) Shares Five Years Ago Are Now Up 39%

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
Analysis Article • Jun 30

Neurones (EPA:NRO) Is Growing Earnings But Are They A Good Guide?

Many investors consider it preferable to invest in profitable companies over unprofitable ones, because profitability...

Revenue & Expenses Breakdown

How Neurones makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

ENXTPA:NRO Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 26888553160
31 Mar 26872543160
31 Dec 25857523160
30 Sep 25845513090
30 Jun 25832513020
31 Mar 25821522950
31 Dec 24810532870
30 Sep 24793512780
30 Jun 24775482690
31 Mar 24758492590
31 Dec 23741492490
30 Sep 23724492400
30 Jun 23707482320
31 Mar 23686462230
31 Dec 22665442150
30 Sep 22642432040
30 Jun 22618411920
31 Mar 22599401830
31 Dec 21580381750
30 Sep 21570371710
30 Jun 21559361660
31 Mar 21542331600
31 Dec 20524311540
30 Sep 20518301510
30 Jun 20511281490
31 Mar 20510301480
31 Dec 19510311470
30 Sep 19505301470
30 Jun 19501301460
31 Mar 19495281450
31 Dec 18490261430
30 Sep 18487261410
30 Jun 18483261380
31 Mar 18484271360
31 Dec 17485271340
30 Sep 17478271300
30 Jun 17470271260
31 Mar 17459261220
31 Dec 16447251170
30 Sep 16436241140
30 Jun 16425231100
31 Mar 16412221050
31 Dec 1539921990
30 Sep 1538621930

Quality Earnings: NRO has high quality earnings.

Growing Profit Margin: NRO's current net profit margins (6.2%) are higher than last year (6.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: NRO's earnings have grown by 7.7% per year over the past 5 years.

Accelerating Growth: NRO's earnings growth over the past year (8.9%) exceeds its 5-year average (7.7% per year).

Earnings vs Industry: NRO earnings growth over the past year (8.9%) exceeded the IT industry 1.3%.

Return on Equity

High ROE: NRO's Return on Equity (14.3%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/10 23:55
End of Day Share Price 2026/09/10 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Neurones S.A. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Alexandre PlaudCIC Market Solutions (ESN)